Holen Sie sich die Stockscreener-App
8.855
10.41%
0.835
Finanzdaten der Sagimet Biosciences Inc-Aktie (SGMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
35.05%
15.82
|
11.71 | 10.77 | 14.33 | 11.93 |
| Operating Income/Loss |
35.05%
-15.82
|
-11.71 | -10.77 | -14.33 | -11.93 |
| Net Income/Loss |
31.01%
-13.95
|
-10.65 | -9.568 | -12.91 | -10.39 |
| Basic Average Shares |
63.13%
53.11
|
32.56 | - | 32.46 | 32.20 |
| Diluted Average Shares |
63.13%
53.11
|
32.56 | - | 32.46 | 32.20 |
| Basic Earnings Per Share |
21.21%
-0.26
|
-0.33 | - | -0.40 | -0.32 |
| Diluted Earnings Per Share |
21.21%
-0.26
|
-0.33 | - | -0.40 | -0.32 |
0.49%
6.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):